AQR Capital Management - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 128 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 4.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$10,582
-48.0%
29,535
-2.8%
0.00%
Q1 2024$20,359
-91.8%
30,378
+90.4%
0.00%
Q4 2020$249,000
+87.2%
15,957
+38.1%
0.00%
Q4 2018$133,000
-84.6%
11,551
-77.3%
0.00%
-100.0%
Q3 2018$861,000
+8.7%
50,782
-8.9%
0.00%0.0%
Q2 2018$792,000
-36.6%
55,740
-15.2%
0.00%0.0%
Q1 2018$1,249,000
+35.0%
65,736
+16.6%
0.00%0.0%
Q4 2017$925,000
+16.5%
56,372
+6.6%
0.00%0.0%
Q3 2017$794,000
+32.1%
52,901
-5.1%
0.00%
-50.0%
Q3 2014$601,000
-29.4%
55,7420.0%0.00%0.0%
Q2 2014$851,000
-15.6%
55,7420.0%0.00%
-33.3%
Q1 2014$1,008,000
+31.8%
55,742
+1.3%
0.00%
+50.0%
Q4 2013$765,000
+10.1%
55,042
-17.0%
0.00%0.0%
Q3 2013$695,000
+34.2%
66,3000.0%0.00%0.0%
Q2 2013$518,000
+402.9%
66,300
+287.7%
0.00%
Q4 2012$103,00017,1000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders